Interferon-γ constrains cytokine production of group 2 innate lymphoid cells

Immunology

Volumn 147, Issue 1, 2016, Pages 21-29

  Kudo, Fujimi ^a   Ikutani, Masashi ^b   Seki, Yoichi ^a   Otsubo, Takeshi ^a   Kawamura, Yuki I ^a   Dohi, Taeko ^a   Oshima, Kenshiro ^c   Hattori, Masahira ^c,d   Nakae, Susumu ^c,e   Takatsu, Kiyoshi ^a,f   Takaki, Satoshi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d WASEDA UNIVERSITY   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f Toyama Prefectural Institute for Pharmaceutical Research   (Japan)

Author keywords

Group 2 innate lymphoid cells; Interferon ; Interleukin 13; Interleukin 5; T helper type 2 cytokines

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; INTERLEUKIN 13; INTERLEUKIN 33; INTERLEUKIN 5; ALPHA-GALACTOSYLCERAMIDE; GALACTOSYLCERAMIDE; GAMMA INTERFERON RECEPTOR; IL33 PROTEIN, MOUSE; INTERFERON RECEPTOR;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL SELECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; GENE EXPRESSION; HELPER CELL; KIDNEY CELL; LUNG ALVEOLUS CELL; LYMPHOID CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; AGONISTS; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; KIDNEY; LUNG; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER T CELL; PHENOTYPE; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; GALACTOSYLCERAMIDES; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-33; INTERLEUKIN-5; KIDNEY; LUNG; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE, INBRED C57BL; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; PHENOTYPE; RECEPTORS, INTERFERON;

EID: 84955199929     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12537     Document Type: Article

References (46)

1. von Moltke J, Locksley RM. I-L-C-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis. Curr Opin Immunol 2014; 31:58-65.
2. Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol 2015; 15:271-82.
3. Licona-Limon P, Kim LK, Palm NW, Flavell RA. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 2013; 14:536-42.
4. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13:145-9.
5. Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells - how did we miss them? Nat Rev Immunol 2013; 13:75-87.
6. McHedlidze T, Waldner M, Zopf S, Walker J, Rankin AL, Schuchmann M et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 2013; 39:357-71.
7. Molofsky AB, Nussbaum JC, Liang HE, Van Dyken SJ, Cheng LE, Mohapatra A et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med 2013; 210:535-49.
8. + lymphoid cells. Nature 2010; 463:540-4.
9. Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A, Molofsky AB et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 2013; 502:245-8.
10. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12:1045-54.
11. Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12:1055-62.
12. Halim TY, Steer CA, Matha L, Gold MJ, Martinez-Gonzalez I, McNagny KM et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 2014; 40:425-35.
13. Van Dyken SJ, Mohapatra A, Nussbaum JC, Molofsky AB, Thornton EE, Ziegler SF et al. Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cells. Immunity 2014; 40:414-24.
14. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18:716-25.
15. Takatsu K, Nakajima H. IL-5 and eosinophilia. Curr Opin Immunol 2008; 20:288-94.
16. Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 2013; 13:9-22.
17. Allen JE, Sutherland TE. Host protective roles of type 2 immunity: parasite killing and tissue repair, flip sides of the same coin. Semin Immunol 2014; 26:329-40.
18. Ikutani M, Yanagibashi T, Ogasawara M, Tsuneyama K, Yamamoto S, Hattori Y et al. Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity. J Immunol 2012; 188:703-13.
19. Eberl G, Colonna M, Di Santo JP, McKenzie AN. Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology. Science 2015; 348:aaa6566.
20. Zaiss DM, Gause WC, Osborne LC, Artis D. Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity 2015; 42:216-26.
21. Halim TY, Krauss RH, Sun AC, Takei F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 2012; 36:451-63.
22. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011; 12:631-8.
23. Gorski SA, Hahn YS, Braciale TJ. Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection. PLoS Pathog 2013; 9:e1003615.
24. Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M, Lahl K et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 2011; 12:1071-7.
25. Kim BS, Wang K, Siracusa MC, Saenz SA, Brestoff JR, Monticelli LA et al. Basophils promote innate lymphoid cell responses in inflamed skin. J Immunol 2014; 193:3717-25.
26. Xue L, Salimi M, Panse I, Mjosberg JM, McKenzie AN, Spits H et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol 2014; 133:1184-94.
27. Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol 2013; 132:205-13.
28. Maazi H, Patel N, Sankaranarayanan I, Suzuki Y, Rigas D, Soroosh P et al. ICOS : ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity 2015; 42:538-51.
29. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-46.
30. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998; 187:561-9.
31. Harris J, De Haro SA, Master SS, Keane J, Roberts EA, Delgado M et al. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 2007; 27:505-17.
32. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995; 2:665-75.
33. H1 priming. Nat Immunol 2004; 5:1260-5.
34. + T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2:271-9.
35. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75:163-89.
36. Taniguchi M, Seino K, Nakayama T. The NKT cell system: bridging innate and acquired immunity. Nat Immunol 2003; 4:1164-5.
37. Else KJ, Finkelman FD, Maliszewski CR, Grencis RK. Cytokine-mediated regulation of chronic intestinal helminth infection. J Exp Med 1994; 179:347-51.
38. Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM. Interferon-γ inhibits experimental renal fibrosis. Kidney Int 1999; 56:2116-27.
39. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A 2010; 107:18581-6.
40. Bando JK, Nussbaum JC, Liang HE, Locksley RM. Type 2 innate lymphoid cells constitutively express arginase-I in the naive and inflamed lung. J Leukoc Biol 2013; 94:877-84.
41. Godfrey DI, Rossjohn J. New ways to turn on NKT cells. J Exp Med 2011; 208:1121-5.
42. Gause WC, Wynn TA, Allen JE. Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol 2013; 13:607-14.
43. Venkataswamy MM, Porcelli SA. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Semin Immunol 2010; 22:68-78.
44. Molofsky AB, Van Gool F, Liang HE, Van Dyken SJ, Nussbaum JC, Lee J et al. Interleukin-33 and interferon-γ counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity 2015; 43:161-74.
45. Vasanthakumar A, Moro K, Xin A, Liao Y, Gloury R, Kawamoto S et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat Immunol 2015; 16:276-85.
46. Bourgeois E, Van LP, Samson M, Diem S, Barra A, Roga S et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production. Eur J Immunol 2009; 39:1046-55.